50% of vaccines are wasted, mainly due to poor refrigeration. Stablepharma's invention is designed to deliver a disruptive solution that can eliminate waste & supply life-saving vaccines to all without refrigeration. Proof of Concept has been achieved & investment is now sought for commercialisation.
Manufacture of basic pharmaceutical products
|Date||Amount||No. of Investors|
|Increase in Cash||-||-|
Financial data drawn from last filed accounts don't necessarily reflect current trading activity.
|SMITH, Nicola Jane||Secretary||17/02/2017|
|CHILD, Nicholas Edward||Director||12/06/2012||British|
|POWELL, Martin Carrick||Director||13/07/2013||British|
|ROSER, Bruce Joseph, Dr||Director||12/01/2012||British|
|SHEPHERD, Robert John||Director||16/07/2016||British|